Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections

Clinica Chimica Acta

Volumn 340, Issue 1-2, 2004, Pages 149-152

  Ciaccio, Marcello ^a,b   Fugardi, Gabriella ^a   Titone, Lucina ^a   Romano, Amelia ^a   Giordano, Salvatore ^a   Bivona, Giulia ^a   Scarlata, Francesco ^a   Vocca, Lavinia ^a   Di Gangi, Maria ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Infection; Marker; Procalcitonin

Indexed keywords

PROCALCITONIN;

ARTICLE; AUTOANALYSIS; BACTERIAL INFECTION; CHILD; HEMATOLOGIC MALIGNANCY; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

BACTERIA (MICROORGANISMS);

EID: 0842281424     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.014     Document Type: Article

References (18)

1. Reinhart K., Carlet J. Procalcitonin - a new marker of severe infection and sepsis. Intensive Care Med. 26:2000;S145.
2. Bracq S., Machason M. Calcitonin gene expression in normal human liver. FEBS. 331:1993;14-18.
3. Gendrel D., Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr. Infect. Dis. J. 19:2000;679-688.
4. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 26:2000;S148-S152.
5. Rau B., Steinbach G., Baumgart K., Gansauge F., Grünert A., Beger H.G. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med. 26:2000;S159-S164.
6. Brunkhorst R., Eberhardt O.K., Haubitz M., Brunkhorst F.M. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med. 26:2000;S199-S201.
7. Fleischhack G., Cipic D., Juettner J., Hasan C., Bode U. Procalcitonin - a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med. 26:2000;S202-S211.
8. Russwurm S., Wiederhold M., Oberhoffer M., Stonans I., Zipfel P.F., Reinhart K. Molecular aspects and natural source of procalcitonin. Clin. Chem. Lab. Med. 37:1999;789-797.
9. Shimetani N., Shimetani K., Mori M. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin , in the serum and cerebrospinal fluid of patients with meningitis. Scand. J. Clin. Lab. Invest. 61:2001;567-574.
10. Martinot M., Hansmann Y., De Martino S., Lesens O., Coumaros G., Pencreach E.et al. Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults. Presse Med. 30:2001;1091-1096.
11. Duflo F., Debon R., Monneret G., Bienvenu J., Chassard D., Allaouchiche B. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology. 96:2002;74-79.
12. Janota J., Stranak Z., Belohlavkova S., Mudra K., Simak J. Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnioitis and neonatal sepsis. Eur. J. Clin. Invest. 31:2001;978-983.
13. Yukioka H., Yoshida G., Kuríta S., Kato N. Plasma procalcitonin in sepsis and organ failure. Ann. Acad. Med. Singapore. 30:2001;528-531.
14. Di Filippo A., Lombardi A., Ognibene A., Messeri G., Tonelli F. Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir. 57:2002;59-62.
15. Penel N., Fournier C., Degardin M., Kouto H., N'Guyen M. Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein. Rev. Med. Interne. 22:2001;706-714.
16. Striz I., Jaresova M., Lacha J., Sedlacek J., Vitko S. MRP 8/14 and procalcitonin serum levels in organ transplantatíons. Ann. Transplant. 6:2001;6-9.
17. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 341:1993;515-518.
18. Svaldi M., Hirber J., Lanthaler A.I., Mayr O., Faes S., Peer E.et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br. J. Haematol. 115:2001;53-57.